运动独立于体重控制延缓肥胖小鼠肝癌发生
研究在DEN注射的肥胖/糖尿病Alms1突变(foz/foz)小鼠中观察运动对肝细胞癌(HCC)发生的影响。运动使12周时GST-pi阳性肝细胞减少,24周HCC发生率降低(15% vs 64%,p<0.05),而配对喂养无此效果。机制涉及改善胰岛素敏感性、激活p53/p27及抑制JNK。
要点
- 运动降低肥胖胰岛素抵抗小鼠DEN诱导的HCC发生率(15% vs 64%)。
- 运动减少癌前病变(GST-pi阳性肝细胞),效果独立于体重变化。
- 保护机制包括p53介导p27诱导和抑制JNK活化。
核心结论
- 运动直接抑制异常增生肝细胞增殖,减少3个月癌前病灶和6个月DEN诱导HCC发生率。
- 运动延缓肝癌发生的潜在机制包括p53介导的p27诱导和预防JNK活化。
研究设计与样本
- 研究使用DEN注射的雄性foz/foz和野生型(WT)同窝小鼠,从第4周至第12或24周给予或不给予跑轮运动。
- 另设foz/foz小鼠与WT同窝配对喂养组,以及通过杂交生成的DEN注射Jnk1-/-.foz/foz小鼠及其遗传对照。
- 通过GST-pi免疫组化鉴定异常增生肝细胞,计数肝结节,并用组织病理学分析HCC。
主要发现
- 运动foz/foz小鼠在10周前体重与WT相似,但24周时变肥胖;配对喂养获得相似体重曲线。
- 12周时运动foz/foz小鼠肝脏GST-pi阳性肝细胞少于久坐对照组。
- 24周时运动foz/foz小鼠HCC发生率低于久坐组(15% vs 64%,p<0.05)。
- 配对喂养foz/foz小鼠未能降低HCC发生率。
- 在胰岛素抵抗foz/foz小鼠中,运动未激活肝脏AMPK或Akt/mTORC1,但改善胰岛素敏感性、减轻脂肪变性和肝损伤、激活p53增加p27表达、阻止JNK活化,并抑制肝细胞增殖。
临床怎么用
- 对于肥胖和胰岛素抵抗的脂肪肝患者,运动可能降低肝癌风险,且该保护作用不完全依赖于体重下降。
局限性
- 研究为小鼠模型,结果不能直接外推至人类。
- 原文未报告运动对非肥胖或非胰岛素抵抗模型的作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Obesity and type 2 diabetes increase hepatocellular carcinoma (HCC) incidence in humans and accelerate diethylnitrosamine (DEN)-induced hepatocarcinogenesis in mice. We investigated whether exercise reduces HCC development in obese/diabetic Alms1 mutant (foz/foz) mice and studied protective mechanisms. METHODS: We measured HCC development in DEN-injected male foz/foz and wild-type (WT) littermates housed with or without an exercise wheel from week 4 until 12 or 24 weeks, and in foz/foz mice pair-fed to WT littermates. We also studied HCC development in DEN-injected Jnk1-/-.foz/foz mice generated by cross breeding, as well as their genetic controls. Dysplastic hepatocytes were identified by glutathione-S-transferase pi form (GST-pi) immunohistochemistry, liver nodules were counted, and HCC was analysed by histopathology. RESULTS: Exercising foz/foz mice maintained similar weight as WT mice up to 10 weeks, but then gained weight and were obese by 24 weeks; a similar body weight profile was obtained by pair-feeding foz/foz mice to WT. At 12 weeks, livers of exercising foz/foz mice exhibited fewer GST-pi positive hepatocytes than sedentary counterparts; by 24 weeks, fewer exercising foz/foz mice developed HCC (15% vs. 64%, p <0.05). Conversely, pair-feeding foz/foz mice failed to reduce HCC incidence. In these insulin-resistant foz/foz mice, exercise failed to activate hepatic AMPK or Akt/mTORC1. Instead, it improved insulin sensitivity, ameliorated steatosis and liver injury, activated p53 to increase p27 expression, and prevented JNK activation. This was associated with suppression of hepatocellular proliferation. DEN-injected Jnk1-/-.foz/foz mice failed to develop liver tumours or HCC at 24 weeks. CONCLUSIONS: Direct effects of exercise dampen proliferation of dysplastic hepatocytes to reduce 3-month dysplastic foci and 6-month incidence of DEN-induced HCC in obese, insulin-resistant mice. The effects of exercise that potentially slow hepatocarcinogenesis include p53-mediated induction of p27 and prevention of JNK activation. LAY SUMMARY: Fatty liver disease commonly occurs alongside obesity and diabetes, contributing to rapidly increasing rates of liver cancer throughout the world. Herein, we show that exercise reduces the incidence and progression of hepatocellular carcinoma in mouse models. The effect of exercise on cancer risk was shown to be independent of changes in weight. Exercise could be a protective mechanism against liver cancer in at-risk individuals.
引用
- Arfianti A, Pok S, Barn V, et al. Exercise retards hepatocarcinogenesis in obese mice independently of weight control. J Hepatol. 2020. PMID: 32302728. doi:10.1016/j.jhep.2020.02.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。